Alfaar, A. S., M. S. Bakry, M. Kamal, S. Ezzat, I. Zaky, H. Taha, A. Ismail, and S. Abouelnaga,
"Accelerating Innovation in Outcomes and Quality of Care Research Through Integration of Clinical Databases; Pediatric Oncology Experience in Egypt",
American Society of Clinical Oncology, Chicago, ASCO - JCO, 2014.
AbstractBackground: Children’s Cancer Hospital -Egypt was established to serve as the country major referral center. Within 6 years the hospital has received 13,865 patients with cancer among 19,744 screened ones. With this rapidly growing number the hospital looked for developing a reliable method for examining the quality of care and supporting health services research as an emerging field in the country. The aim of this paper is to describe the role of integrating several databases in providing a 360 view for healthcare picture. Methods: We have developed an online cancer registry database using RedCap data capture system to gather patients data from different sources. This database was integrated with the electronic medical records to share new patients data instantaneously. Two nurses were trained to curate the database daily and act as human quality control gateway. Cancer registry provided data about 19,927 patients were examined between 2007 and 2013. The second aspect was provided by digitizing and Optical Character Recognition of 12,573 pathology paper-based reports. Pathology reports were analysed electronically to extract dates, initial and final diagnoses, gross and microscopic pictures and markers used for diagnosis. A third aspect was added to the model by mining Radiology Information System database to extract 258,632 studies for all patients. Radiological studies were organized to show the type of investigation, time needed and outcome. Results: A unified comprehensive new database was developed showing uncountable number of quality of care indices and correlations between different initial and final timepoints. Those indicators included delay of diagnosis, reporting and difference in outcomes correlated with epidemiological aspects. The time used to develop this database was two weeks in the first time. A standard operating procedures was developed to decrease time during future updates. Conclusions: Accelerated pathway to research can be acquired in any settings including unprivileged low-middle income countries via structured reporting, integration between different databases and using simple information technology skills.
Zekri, W., A. S. AlFaar, D. Yehia, M. ElShafie, M. Saad Zaghlol, H. Taha, N. ElKinaee, A. Refaat, and A. Younis,
"Clear Cell Sarcoma of The Kidney",
European Multidisciplinary Cancer Congress, Amsterdam, Elsevier, 2013.
Abstractn/a
Alei Eldin, A., A. Haddad, H. Elzomor, Y. Medhat, H. Taha, M. Saad, E. Zaky, R. A. ElRazk, M. Elshamy, S. Abouelnaga, et al.,
"Evaluation of Retinoblastoma management in the first Multidisciplinary system in the Cancer children hospital in Egypt",
International Society of Ocular Oncology Meeting, Purpose: To evaluate the success of ocular survival following chemoreduction and efficency of local treatment in the management of Retinoblastoma in the first multidisciplinary system for the treatment of childhood cancer in egypt Methods: A total number , 2013.
AbstractPurpose: To evaluate the success of ocular survival following chemoreduction and efficency of local treatment in the management of Retinoblastoma in the first multidisciplinary system for the treatment of childhood cancer in egypt Methods: A total number of 262 retinoblastomas cases managed between July 2007 to December 2012 with six cycles of chemoreduction (vincristine, etoposide, and carboplatin (COG protocols). The tumors were then managed with local treatment alone (group A) or chemoreduction combined with , cryotherapy or Diode laser (group B and C) and some cases of group D. In addition to enucleation for group E and advanced cases . Results: Of 262 retinoblastomas cases , (0.9%) were in group A, (8.4%) in group B, (11.7%) in group C, (44.4%) in group D,and (33.6) in group E. The mean age at presentation is 21.17 months .Bilateral affection was in 43% and unilateral in 57%. Family history of cancer was 11% and consangunity was positive in 19%. Extraocular involvement was in 18% of cases . Incidence of ocular survival for bilateral cases was 95% in group A ,80% in group B 45% in group C and 35% in group D ,while in unilateral cases it was 80%in group B ,50% in group C ,15% in group D . Conclusions: There is no doubt that the application of different treatment modalities among a multidisciplinary system in the treatment of retinoblastoma in the cancer children hospital gives a very good percentage of success despite the relatively late presentation and the higher incidence of advanced cases Financial disclosure: There is no financial disclosure Paper
Elzomor, H., R. Nour, A. S. Alfaar, A. Alei Eldin, S. M. Zaghloul, H. Taha, and A. Elhaddad,
"Presentation Of Extra-Ocular Retinoblastoma In Egypt",
International Society of Genetic Eye Diseases and Retinoblastoma meeting., Gent, Belgium, pp. 71, 2013.
AbstractIntroduction: Extraocular Retinoblastoma is a disease of developing countries. It represents a challenge for oncologists with its poor prognosis and resistance to chemotherapy. There is a major discrepancy in reporting its incidence between developing and developed world. Egypt represents the third most populous African country, hence, establishing Childrenâ?Ts Cancer Hospital Egypt 57357 (CCHE) -a non for profit institute- represents a hope for childhood cancer patients in Egypt and the middle-east. The aim of this paper is to report the magnitude of the disease and presenting features of extraocular retinoblastoma in Egypt over the last 6 years. Materials & Methods: We reviewed all the cases that were presented with extraocular retinoblastoma to our center between July 2007 and December 2012. This included ISGEDR 2013 72 reviewing clinical, radiological and pathological investigations. Cases were classified based on international staging of Retinoblastoma and milestone of diagnosing the disease. Results: Between July 2007 and December 2012 our team has diagnosed 48 cases of metastatic disease accounting for 18.3% of all cases with retinoblastoma. Mean age of presentation was 27.3 months and duration of prior symptoms was 17 months. 40% of the cases presented initially with extra-ocular retinoblastoma while 49% was diagnosed after enucleation and about 9% of the cases ignored followup sessions and came later with metastases. Stage II represented 32.4% of the cases while Stage III was 26.4% and Stage IV accounted for 42.2 % of the cases. Conclusions: Extraocular retinoblastoma is still an under-studied field due to the few diagnosed cases in developed world. But in the settings of developing countries it represents a real nightmare specially with the increasing number of advanced intra- ocular retinoblastoma patients and lack of access to healthcare services.
Alfaar, A. S., R. Labib, S. Ezzat, M. Mostafa, H. Taha, and S. Abouelnaga,
"Telepathology to Improve Collaboration and Quality of Samples Annotation in Biorepository. ",
ISBER Annual Meeting, Orlando, Florida, 2014.
AbstractBackground: Telemedicine is the field of using information and communication technologies for facilitating diagnosis and treatment at distance. Using such disciplines in pathology has started long time ago with using closed TV circuits between teams. We’ve piloted the integration between caTissue open source biorepository suite and our telepathology system to facilitate verifying the diagnosis of stored and released samples. Methods: We have used LeicaTM telepathology system to produce digital formats for pathology slides of samples sent for biobanking. The diagnosis of scanned sets was discussed with our partners in US. We had implemented caTissue biorepository suite for handling the samples data including annotation. We’ve piloted using both caTissue 1.2 and caTissue plus 3.0 systems for integration with shared slides and reports. Results: Ninety-four tissue samples have been collected and stored . 109 slides/samples have been digitized for archival and assisting later annotation . Samples have been shared with our partners for discussion. H&E and biomarkers-labeled studies was used. New caTissue Plus 3.0 has proven more flexibility in sharing the annotations and reviewing the online slides. Conclusions: Telepathology has provided a new dimension for annotating sampled specimens giving an opportunity for researchers to discuss the cases without the need to get the physical samples.